List of insiders holdings for Lyell Immunopharma Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| NELSEN ROBERT Director 10% Owner | 2024-06-17 16:41:47 | 130,000 36,412,716 | 36,542,716 | Form 4 |
| ARCH Venture Partners IX LLC ARCH Venture Fund IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Partners IX L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner | 2024-02-14 15:18:45 | 36,477,716 0 | 36,477,716 | Form 13G |
| GLAXOSMITHKLINE PLC 10% Owner | 2022-02-10 16:51:33 | 30,253,189 0 | 30,253,189 | Form 13G |
| Bishop Hans Edgar Director | 2024-06-17 16:17:47 | 4,815,614 0 | 4,815,614 | Form 4 |
| Klausner Richard Director | 2024-06-17 16:15:57 | 3,097,834 685,365 | 3,783,199 | Form 4 |
| Homans Elizabeth Chief Executive Officer | 2022-03-18 16:07:26 | 1,479,500 0 | 1,479,500 | Form 4 |
| Albertson Tina M. Chief Medical Officer | 2023-02-28 18:19:25 | 704,049 0 | 704,049 | Form 4 |
| Lang Matthew Chief Business Officer | 2024-02-13 20:25:36 | 550,000 0 | 550,000 | Form 4 |
| FRIEDMAN CATHY Director | 2024-06-17 16:05:21 | 130,000 336,370 | 466,370 | Form 4 |
| Lee Gary K. Chief Scientific Officer | 2024-02-13 20:22:01 | 452,700 0 | 452,700 | Form 4 |
| Hill Stephen J. Chief Operating Officer | 2024-02-13 20:24:01 | 448,928 0 | 448,928 | Form 4 |
| Newton Charles W. Chief Financial Officer | 2024-02-13 20:19:16 | 448,729 0 | 448,729 | Form 4 |
| Turner Heather D Chief General Counsel | 2022-03-18 16:11:11 | 300,000 0 | 300,000 | Form 4 |
| Ramachandra Sumant Director | 2024-11-01 16:56:39 | 260,000 0 | 260,000 | Form 4 |
| Thompson Rahsaan Chief Legal Officer | 2023-02-28 18:15:29 | 245,000 0 | 245,000 | Form 4 |
| Seely Lynn President and CEO | 2024-02-13 20:17:30 | 200,000 0 | 200,000 | Form 4 |
| BRAWLEY OTIS W Director | 2024-06-17 16:07:23 | 130,000 0 | 130,000 | Form 4 |
| NABEL ELIZABETH G Director | 2024-06-17 16:09:09 | 130,000 0 | 130,000 | Form 4 |
| RIEFLIN WILLIAM JL Director | 2024-06-17 16:13:24 | 130,000 0 | 130,000 | Form 4 |